Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “aspart”

34 pharma patents match "aspart" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 34
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 34 pharmaceutical patents matching "aspart" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

34 results for “aspart” · 30,257 patents in full index Clear search

  1. US 6469027

    N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 22, 2002 · Expires Oct 17, 2022

    expired

  2. US 6436989

    Prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 20, 2002 · Expires Aug 15, 2022

    expired

  3. US 6407080

    N-(pyrimidinyl)-aspartic acid analogs as interleukin-1&bgr; converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 18, 2002 · Expires Jun 13, 2022

    expired

  4. US 6392046

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted May 21, 2002 · Expires May 16, 2022

    expired

  5. US 6372778

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 16, 2002 · Expires Apr 11, 2022

    expired

  6. US 6319946

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2001 · Expires Nov 15, 2021

    expired

  7. US 6162800

    N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2000 · Expires Dec 14, 2020

    expired

  8. US 6127372

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2000 · Expires Sep 28, 2020

    expired

  9. US 6025369

    N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 15, 2000 · Expires Feb 10, 2020

    expired

  10. US 6017957

    Partial agonists of the strychnine insensitive glycine modulatory site of the N-methyl-D-aspartate receptor complex as neuropsychopharmacological agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 25, 2000 · Expires Jan 20, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.